Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net earnings/(loss)	$ (4,921)	$ 594
Adjustments to reconcile net earnings/(loss) to net cash provided by/(used in) operating activities:
Depreciation and amortization	234	245
Impairments and (gain)/loss on sale of investments	0	2
Impairments and (gain)/loss on disposal of assets, net	1	(511)
Share-based compensation	(20)	(19)
Provision for bad debts	29	21
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
(Increase)/decrease in trade receivables	229	(302)
(Increase)/decrease in inventories	356	(178)
Increase/(decrease) in accounts payable	(1,812)	559
Other accrued liabilities and operating items, net	5,211	(84)
Net cash provided by/(used in) operating activities	(653)	365
Cash flows from investing activities:
Additions to property and equipment	(72)	(58)
Purchase of available-for-sale securities and other investments	(3)	(4)
Proceeds from sale of available-for-sale securities and other investments	2	1
Proceeds from Sale of Property, Plant, and Equipment	0	740
Net cash provided by/(used in) investing activities	(73)	679
Cash flows from financing activities:
Net change in short-term borrowings	(2)	0
Reduction of long-term obligations	(74)	(1)
Net tax proceeds/(withholdings) from share-based compensation	(13)	(13)
Dividends on common shares	(146)	(150)
Purchase of treasury shares	(350)	(600)
Net cash used in financing activities	(585)	(764)
Effect of exchange rate changes on cash and equivalents	(8)	2
Net increase/(decrease) in cash and equivalents	(1,319)	282
Cash and equivalents at beginning of period	2,531	1,763
Cash and equivalents at end of period	$ 1,212	$ 2,045